Actinex and Chronic obstructive pulmonary disease - a phase IV clinical study of FDA data
Chronic obstructive pulmonary disease is reported only by a few people who take Actinex.
The phase IV clinical study analyzes which people take Actinex and have Chronic obstructive pulmonary disease. It is created by eHealthMe based on reports of 8 people who have side effects while taking Actinex from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
8 people reported to have side effects when taking Actinex.
Among them, 2 people (25.0%) have Chronic obstructive pulmonary disease.
What is Actinex?
Actinex has active ingredients of masoprocol. eHealthMe is studying from 10 Actinex users for its effectiveness, alternative drugs and more.
What is Chronic obstructive pulmonary disease?
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe) is found to be associated with 2,699 drugs and 2,007 conditions by eHealthMe.
Number of Actinex and Chronic obstructive pulmonary disease reports submitted per year:
Gender of people who have Chronic obstructive pulmonary disease when taking Actinex*:
Age of people who have Chronic obstructive pulmonary disease when taking Actinex *:
Common drugs people take besides Actinex *:
Common side effects people have besides Chronic obstructive pulmonary disease *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Actinex and have Chronic obstructive pulmonary disease?Check whether Chronic obstructive pulmonary disease is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Chronic obstructive pulmonary disease and when was it recovered:
Expand to all the drugs that have ingredients of masoprocol:
Alternative drugs to, pros and cons of Actinex:
- Actinex (10 reports)
Chronic obstructive pulmonary disease treatments and more:
- Chronic obstructive pulmonary disease (180,000 reports)
COVID vaccines that are related to Chronic obstructive pulmonary disease:
- Chronic obstructive pulmonary disease in Moderna COVID Vaccine
- Chronic obstructive pulmonary disease in Pfizer BioNTech Covid Vaccine
- Chronic obstructive pulmonary disease in Johnson and Johnson Covid Vaccine
Common drugs associated with Chronic obstructive pulmonary disease:
- Spiriva: 7,121 reports
- Prednisone: 5,692 reports
- Symbicort: 4,676 reports
- Aspirin: 4,628 reports
- Albuterol: 3,918 reports
- Fosamax: 2,947 reports
- Furosemide: 2,933 reports
- Lasix: 2,829 reports
- Lisinopril: 2,490 reports
- Omeprazole: 2,415 reports
All the drugs that are associated with Chronic obstructive pulmonary disease:
- Chronic obstructive pulmonary disease (2,699 drugs)
Common conditions associated with Chronic obstructive pulmonary disease:
- Rheumatoid arthritis: 3,895 reports
- Osteoporosis: 3,472 reports
- Asthma: 3,370 reports
- High blood pressure: 3,274 reports
All the conditions that are associated with Chronic obstructive pulmonary disease:
- Chronic obstructive pulmonary disease (2,007 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on masoprocol (the active ingredients of Actinex) and Actinex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Agitation in Latuda, how severe and when it was recovered? - now
- Talwin vs. Opana - 2 seconds ago
- Gastric Disorder and Constipation - 4 seconds ago
- Amitiza and High Blood Pressure - 8 seconds ago
- Oxybutynin and Skin Burning Sensation - 8 seconds ago
- Ciprofloxacin and Urge Incontinence - 9 seconds ago
- Fexofenadine Hydrochloride and Pantethine drug interaction - 26 seconds ago
- Sansert and Corgard drug interaction - 26 seconds ago
- Diphen and Ridaura drug interaction - 29 seconds ago
- Hydrocortisone Sodium Succinate and Dyskinesia Aggravated - 34 seconds ago